Lead Discovery Center, Merck Partner on Kinase Inhibitor Discovery | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Max Planck Innovation spinout, the Lead Discovery Center, today announced a collaboration with Merck for the discovery of kinase inhibitors as potential cancer treatments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.